Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment

Bibliographic Details
Main Author:	Miguel Angel Martinez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 repurposed drugs treatment efficacy HIV HCV
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.635371/full

Similar Items

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
by: Kamini Govender, et al.
Published: (2022-11-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

Drug Repurposing Approaches to Combating Viral Infections
by: Jay Trivedi, et al.
Published: (2020-11-01)

Editorial: Drug Repurposing for COVID-19 Therapy
by: Rafael Maldonado, et al.
Published: (2021-08-01)

Psychotropic drug repurposing for COVID-19: a systematic review
by: U. Isayeva, et al.
Published: (2022-06-01)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
by: Janet Sultana, et al.
Published: (2020-11-01)

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
by: Fadhl M. Alakwaa
Published: (2020-04-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
by: Chow Suet-May, et al.
Published: (2022-12-01)

Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics
by: Bhaswati Chatterjee, et al.
Published: (2022-05-01)

Drug Repurposing and Dosage Form Development of Anti-COVID-19
by: Kevin Kwok
Published: (2021-04-01)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
by: Safaet Alam, et al.
Published: (2021-06-01)

Use of repurposed drugs in COVID-19 pandemic: Old drugs without new tricks?
by: Suraj Kapoor
Published: (2023-01-01)

Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages
by: Xin Wang, et al.
Published: (2023-03-01)

Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19
by: Michael A. Kiebish, et al.
Published: (2021-03-01)

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
by: Abas Sezer, et al.
Published: (2022-05-01)

Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease
by: Ahmed Ali Al-Karmalawy, et al.
Published: (2021-11-01)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
by: Pawan Kumar Raghav, et al.
Published: (2023-05-01)

Repurposed antimicrobial and antiviral drugs for COVID-19 treatment: safety and side effects in real clinical practice (scientific review)
by: Marina V. Leonova
Published: (2022-09-01)

Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
by: Paulo Nunes, et al.
Published: (2023-05-01)

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
by: Christopher A. MacRaild, et al.
Published: (2022-10-01)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
by: José Miguel Vela
Published: (2020-11-01)

Saquinavir: From HIV to COVID-19 and Cancer Treatment
by: Mariana Pereira, et al.
Published: (2022-07-01)

Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
by: Zhou G, et al.
Published: (2023-09-01)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
by: Dan-Yang Liu, et al.
Published: (2021-04-01)

The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
by: Chiranjib Chakraborty, et al.
Published: (2021-11-01)

COVID-19 Drug Repurposing: A Network-Based Framework for Exploring Biomedical Literature and Clinical Trials for Possible Treatments
by: Ahmed Abdeen Hamed, et al.
Published: (2022-03-01)

Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
by: Vivek P. Chavda, et al.
Published: (2021-12-01)

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
by: Paola Stolfi, et al.
Published: (2020-10-01)

Buying time: Drug repurposing to treat the host in COVID‐19H
by: Jennifer H. Martin, et al.
Published: (2020-08-01)

Potential COVID-19 papain-like protease PLpro inhibitors: repurposing FDA-approved drugs
by: Valentina L. Kouznetsova, et al.
Published: (2020-09-01)

Antidepressant drug treatment protecting from COVID-19: one more piece in the repurposing puzzle
by: Julia C. Stingl
Published: (2022-01-01)

A fuzzy logic-based computational method for the repurposing of drugs against COVID-19
by: Yosef Masoudi-Sobhanzadeh, et al.
Published: (2022-07-01)

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
by: Rudra P. Saha, et al.
Published: (2020-08-01)

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
by: Mario Roberto Senger, et al.

Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
by: Tamizhini Loganathan, et al.
Published: (2020-06-01)

Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
by: Frauke Assmus, et al.
Published: (2022-08-01)

Revisiting the COVID-19 Pandemic: An Insight into Long-Term Post-COVID Complications and Repurposing of Drugs
by: Rajib Majumder, et al.
Published: (2023-04-01)

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
by: Liliana Rodrigues, et al.
Published: (2022-04-01)

Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
by: Yow Hui Yin, et al.
Published: (2022-09-01)